Citizens Financial Group Inc Blueprint Medicines Corp Call Options Transaction History
Citizens Financial Group Inc
- $4.97 Billion
- Q1 2025
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding BPMC
# of Institutions
390Shares Held
68.6MCall Options Held
1.54MPut Options Held
1.08M-
Black Rock Inc. New York, NY6.65MShares$665 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.64MShares$664 Million0.01% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD5.42MShares$542 Million0.06% of portfolio
-
Avoro Capital Advisors LLC New York, NY3.85MShares$385 Million5.51% of portfolio
-
Wellington Management Group LLP Boston, MA3.07MShares$308 Million0.05% of portfolio
About Blueprint Medicines Corp
- Ticker BPMC
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 59,719,600
- Market Cap $5.98B
- Description
- Blueprint Medicines Corporation, a precision therapy company, develops medicines for genomically defined cancers and blood disorders in the United States and internationally. The company is developing AYVAKIT for the treatment of systemic mastocytosis (SM) and gastrointestinal stromal tumors; BLU-263, an orally available, potent, and KIT inhibit...